Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Ritter

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|April 9, 2011
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertensionJ M Ritter
British Journal of Clinical Pharmacology|November 3, 2010
More on first-in-man studiesJ M Ritter
British Journal of Clinical Pharmacology|February 3, 2011
Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)J M Ritter
British Journal of Clinical Pharmacology|April 22, 2010
Novel targets and regulatory ordeal by QT intervalJ M Ritter
British Journal of Clinical Pharmacology|July 27, 2010
Human models of hyperalgesia and pain (chilli pepper with your acid indigestion, Sir?)J M Ritter
Lancet (London, England)|May 24, 1980
Placebo-controlled, double-blind clinical trials can impede medical progressJ M Ritter
British Journal of Clinical Pharmacology|February 29, 2008
Pharmacokinetic(s) matters: stroke treatment et ceteraJ M Ritter
British Journal of Clinical Pharmacology|May 15, 2008
Drug regulation & therapeutic efficacyJ M Ritter
British Journal of Clinical Pharmacology|September 11, 2008
Drug-induced long QT syndrome and drug developmentJ M Ritter
British Journal of Clinical Pharmacology|November 27, 2008
Money makes the world go round: the pervasiveness of pharmacoeconomicsJ M Ritter
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|April 9, 2011
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertensionJ M Ritter
British Journal of Clinical Pharmacology|November 3, 2010
More on first-in-man studiesJ M Ritter
British Journal of Clinical Pharmacology|February 3, 2011
Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)J M Ritter
British Journal of Clinical Pharmacology|April 22, 2010
Novel targets and regulatory ordeal by QT intervalJ M Ritter
British Journal of Clinical Pharmacology|July 27, 2010
Human models of hyperalgesia and pain (chilli pepper with your acid indigestion, Sir?)J M Ritter
Lancet (London, England)|May 24, 1980
Placebo-controlled, double-blind clinical trials can impede medical progressJ M Ritter
British Journal of Clinical Pharmacology|February 29, 2008
Pharmacokinetic(s) matters: stroke treatment et ceteraJ M Ritter
British Journal of Clinical Pharmacology|May 15, 2008
Drug regulation & therapeutic efficacyJ M Ritter
British Journal of Clinical Pharmacology|September 11, 2008
Drug-induced long QT syndrome and drug developmentJ M Ritter
British Journal of Clinical Pharmacology|November 27, 2008
Money makes the world go round: the pervasiveness of pharmacoeconomicsJ M Ritter
Pageof 17